Cargando…
Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study
Medication-overuse headache (MOH) represents a severely disabling condition, with a low response to prophylactic treatments. Recently, consistent evidences have emerged in favor of botulinum toxin type-A (onabotulinum toxin A) as prophylactic treatment in chronic migraine. In a 12-week double-blind,...
Autores principales: | Sandrini, Giorgio, Perrotta, Armando, Tassorelli, Cristina, Torelli, Paola, Brighina, Filippo, Sances, Grazia, Nappi, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139089/ https://www.ncbi.nlm.nih.gov/pubmed/21499747 http://dx.doi.org/10.1007/s10194-011-0339-z |
Ejemplares similares
-
Rehabilitation from symptomatic drugs overuse: yes, no, may be
por: Tassorelli, Cristina, et al.
Publicado: (2015) -
P008. Alexithymia and chronic migraine with medication overuse: what relationship?
por: Bottiroli, Sara, et al.
Publicado: (2015) -
EHMTI-0147. Medication overuse headache and alexithymia: a controlled study
por: Sances, G, et al.
Publicado: (2014) -
Reducing the costs of headache: an Italian approach
por: Citterio, Antonietta, et al.
Publicado: (2003) -
The “care” protocol: the role of personality in a three-year follow-up study of medication overuse headache
por: Galli, F, et al.
Publicado: (2013)